SEC Filing Summary: Tempur-Pedic International Inc. (10-K)
Business Context and Reporting Period
Company: Tempur-Pedic International Inc. (Note: Input metadata referenced "SOMNIGROUP," but the filing text identifies the registrant as Tempur-Pedic International Inc.)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2007
Filing Date: February 13, 2008
Business Overview: The Company is the leading manufacturer and distributor of premium mattresses and pillows sold under the TEMPUR and Tempur-Pedic brands in approximately 80 countries. Operations are divided into two segments: Domestic (U.S. manufacturing and distribution) and International (Denmark manufacturing and global distribution). The Company utilizes proprietary, temperature-sensitive viscoelastic material.
Key Financial Metrics (Year Ended Dec 31, 2007)
| Metric | 2007 | 2006 |
|---|---|---|
| Net Sales | $1,106.7 million | $945.0 million |
| Gross Profit | $534.8 million | $460.5 million |
| Gross Margin | 48.3% | 48.7% |
| Operating Income | $244.1 million | $209.3 million |
| Operating Margin | 22.1% | 22.1% |
| Net Income | $141.5 million | $112.3 million |
| Diluted EPS | $1.74 | $1.28 |
| Cash from Operations | $126.4 million | $165.8 million |
| Total Debt | $602.0 million | $361.1 million |
| Stockholders' Equity | $48.1 million | $213.3 million |
| Cash & Equivalents | $33.3 million | $15.8 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 17.1% to $1.1 billion, driven primarily by a 21.1% increase in Retail channel sales and a 17.9% increase in mattress sales.
- Profitability: Net income rose 26.0% to $141.5 million. Operating income increased 16.6% to $244.1 million.
- Debt & Leverage: Total debt increased significantly from $361.1 million to $602.0 million. This increase was primarily due to borrowings used to fund a $319.9 million share repurchase program and the initiation of a cash dividend program.
- Equity Reduction: Stockholders' equity decreased from $213.3 million to $48.1 million, largely due to the repurchase of 11.1 million shares of common stock.
- Cash Flow: Operating cash flow decreased by $39.4 million to $126.4 million, primarily due to a $59.5 million increase in inventory levels to prevent shortages and prepare for new product launches.
Guidance, Outlook, Risks, and Unusual Items
- Outlook & Strategy: Management plans to continue investing in global brand awareness, expand retail distribution (targeting 7,000–8,000 U.S. stores), and introduce new products (e.g., "AlluraBed," "Advanced Ergo System"). Capital expenditures for 2008 are expected to be approximately $20.0 million.
- Dividends: The Company initiated a cash dividend program in 2007. A quarterly dividend of $0.08 per share was declared for Q1 2008.
- Executive Transition: CEO H. Thomas Bryant announced his retirement effective mid-year 2008.
- Key Risks:
- Competition: Intense competition from innerspring manufacturers (Sealy, Serta, Simmons) and other specialty sleep products.
- Raw Materials: Exposure to fluctuations in the cost of chemicals and proprietary additives.
- Legal Proceedings: Pending securities class action lawsuits regarding 2005 disclosures and an antitrust class action (though the antitrust complaint was largely dismissed, plaintiffs filed a motion to alter judgment). Additionally, the Company received a tax assessment from the Danish Tax Authority regarding 2001–2003 royalties.
- Financial Leverage: High debt levels limit flexibility and increase the risk of default if profitability declines.
Investor Verification Checklist
- Debt Covenants: Verify compliance with financial covenants (interest coverage and leverage ratios) given the high debt load of $602 million.
- Inventory Levels: Monitor inventory build-up ($106.5 million in 2007 vs. $61.7 million in 2006) to ensure it converts to sales and does not require write-downs.
- CEO Succession: Assess the impact of the CEO's mid-2008 retirement on strategic execution.
- Legal Exposure: Track the status of the Danish tax assessment and the securities class action litigation.
- Share Repurchases: Confirm the remaining authorization under the $300 million repurchase program initiated in October 2007.